Tri Locum Partners LP
CIK 0001826434
Annualised vol
12.146689%
Beta
0.379415
HHI
784.177985
Top-10 weight
79.998676%
VaR 95%
1.132581%
VaR 99%
1.952502%
Max drawdown
13.774595%
Matched value
79.982699%
Returns of reported holdings
Loading returns…
Position changes vs prior quarter
What the latest 13F shows bought and sold against the quarter before, by share count.
| Ticker | Change | Shares now | Shares before | Share change % | Value now ($) |
|---|---|---|---|---|---|
| JNJ | ADDED | 424,945 | 414,503 | 2.52% | 107,923,282 |
| LLY | ADDED | 76,532 | 61,795 | 23.85% | 91,794,777 |
| ASND | ADDED | 258,740 | 255,332 | 1.33% | 69,011,133 |
| DXCM | ADDED | 820,479 | 698,158 | 17.52% | 55,259,261 |
| AXSM | ADDED | 219,308 | 62,116 | 253.06% | 53,680,019 |
| JAZZ | ADDED | 221,720 | 158,663 | 39.74% | 53,427,868 |
| ELVN | NEW | 866,716 | - | - | 43,985,837 |
| ARGX | ADDED | 41,596 | 31,635 | 31.49% | 38,591,521 |
| MDGL | REDUCED | 68,273 | 103,288 | -33.9% | 36,659,187 |
| RVMD | NEW | 151,822 | - | - | 28,433,224 |
| TARS | ADDED | 328,340 | 252,588 | 29.99% | 20,665,720 |
| ISRG | REDUCED | 47,983 | 153,250 | -68.69% | 19,081,879 |
| CYTK | NEW | 194,000 | - | - | 16,526,860 |
| BBNX | NEW | 493,344 | - | - | 7,730,700 |
| DFTX | REDUCED | 162,996 | 369,588 | -55.9% | 7,667,332 |
| TMO | CLOSED OUT | 0 | 132,413 | -100.0% | 0 |
Holdings (latest quarter)
| Ticker | Change | Issuer | Class | CUSIP | Value ($) | Weight % | Shares |
|---|---|---|---|---|---|---|---|
| JNJ | ADDED | JOHNSON & JOHNSON | COM | 478160104 | 107,923,282 | 13.27 | 424945.0 |
| - | VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 100,235,643 | 12.33 | 201791.0 | |
| LLY | ADDED | ELI LILLY & CO | COM | 532457108 | 91,794,777 | 11.29 | 76532.0 |
| ASND | ADDED | ASCENDIS PHARMA A/S | ORD SHS | K08588103 | 69,011,133 | 8.49 | 258740.0 |
| DXCM | ADDED | DEXCOM INC | COM | 252131107 | 55,259,261 | 6.8 | 820479.0 |
| AXSM | ADDED | AXSOME THERAPEUTICS INC. | COM | 05464T104 | 53,680,019 | 6.6 | 219308.0 |
| JAZZ | ADDED | JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | 53,427,868 | 6.57 | 221720.0 |
| ELVN | NEW | ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 43,985,837 | 5.41 | 866716.0 |
| ARGX | ADDED | ARGENX SE | SPONSORED ADR | 04016X101 | 38,591,521 | 4.75 | 41596.0 |
| MDGL | REDUCED | MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 36,659,187 | 4.51 | 68273.0 |
| RVMD | NEW | REVOLUTION MEDICINES INC | COM | 76155X100 | 28,433,224 | 3.5 | 151822.0 |
| - | UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 25,480,098 | 3.13 | 47026.0 | |
| - | TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 881624209 | 25,302,770 | 3.11 | 746835.0 | |
| TARS | ADDED | TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 20,665,720 | 2.54 | 328340.0 |
| ISRG | REDUCED | INTUITIVE SURGICAL INC | COM NEW | 46120E602 | 19,081,879 | 2.35 | 47983.0 |
| CYTK | NEW | CYTOKINETICS INC | COM NEW | 23282W605 | 16,526,860 | 2.03 | 194000.0 |
| - | DIANTHUS THERAPEUTICS INC | COM | 252828108 | 11,767,006 | 1.45 | 120712.0 | |
| BBNX | NEW | BETA BIONICS INC | COM | 08659B102 | 7,730,700 | 0.95 | 493344.0 |
| DFTX | REDUCED | DEFINIUM THERAPEUTICS INC | COM SHS | 24477V105 | 7,667,332 | 0.94 | 162996.0 |
Quarterly portfolios
| Period | Filed | Value ($) | Positions | Vol % | Beta | Max DD % |
|---|---|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | 813,224,117 | 19 | 12.146689 | 0.379415 | 13.774595 |
| 2026-03-31 | 2026-05-18 | 712,549,412 | 17 | 10.920201 | 0.403278 | 15.383574 |
| 2025-12-31 | 2026-02-17 | 770,122,933 | 15 | 10.221606 | 0.319534 | 12.586804 |
| 2025-09-30 | 2025-11-14 | 435,052,388 | 18 | 10.079253 | 0.22031 | 10.758221 |
| 2025-03-31 | 2025-05-14 | 194,900,511 | 22 | 8.837592 | 0.244047 | 10.650598 |
| 2024-12-31 | 2025-02-14 | 482,730,651 | 28 | 8.88082 | 0.267681 | 14.840735 |